ABPI Code of Practice - an
Overview (Published 19 January 2004) All promotional activity
undertaken by pharmaceutical companies is covered by the requirements of the
Association of the British Pharmaceutical Industry (ABPI) Code of Practice. The
aim of the Code is that all promotion should be responsible, ethical and
professional (It is probably only a coincidence that this abbreviates to
R.E.P., but it is an easy way to remember it.)
The Code
itself is a self-regulatory system, but it reflects the requirements of the
Medicines Act and the European Advertising Directives, which are legally
binding. The Code only covers pharmaceutical companies, while the legislation
also covers doctors, pharmacists and other health professionals.
Why
do representatives need to know about the Code? Firstly, questions on the Code
are now a compulsory part of the ABPI Representatives Examination. Unless
representatives pass this exam within two years of starting work, they cannot
be employed as representatives. Secondly, and arguably more importantly,
representatives who dont know about the Code, can get their companies
into trouble.
The Code operates as a complaints system. Complaints are
accepted from any source, but tend to come mainly from doctors or other health
professionals, or from pharmaceutical companies - usually competitors.
Complaints are fully investigated by the Prescription Medicines Code of
Practice Authority (PMCPA) and if it is decided that a company has breached the
Code in any way, the company will be fined. For serious breaches, the company
may be required to undergo an audit or may be publicly reprimanded. Full
details of the complaint and the outcome are published, quarterly, in the Code
of Practice Review.
The Code covers everything which can be considered
to promote the use of a companys medicine. This can cover a wide variety
of activities, including advertising, mailings, public relations, meetings.
Most importantly, it covers ALL representative activity. It is considered that
a representatives job, essentially, is to sell i.e. to promote.
Representatives therefore are considered inherently promotional, and the Code
thus covers everything they do, say, use or pay for.
The Code is a
fairly substantial document, which sets out the requirements in relation to
different promotional activities. The requirements are sometimes very detailed,
and sometimes more general points of principle, which may need some
interpretation. One section deals specifically with representatives but it is
important for representatives to be familiar with all of the Code, as many of
the other sections are highly relevant to their work.
Promotional
material
There are extensive and detailed requirements relating to
the content of promotional material - advertisements, mailings, details aids
etc. The overriding principle is that every piece of promotional material must
be accurate and balanced, and should not mislead the reader in any way.
Further, every statement must be capable of substantiation, which
means that there must be data to support it. Companies must have rigorous
approval procedures to make sure that all material complies fully with Code
requirements.
Representative calls
The principle here
is that doctors and other health professionals should not be subjected to
unacceptable selling techniques. The Code covers the timing and convenience of
calls, and prohibits offering any sort of incentive to see a representative.
The principle which applies to written material - that it should be accurate,
balanced etc - applies equally to everything that is said during a call.
Gifts to health professionals
The principle here is
that there must be no suggestion that doctors are rewarded in any way for
writing prescriptions. Low value (up to £6.00) giveaways are allowed,
provided they are relevant to medical practice - pens, pads, tourniquets etc.
Donations of items of greater value e.g. medical equipment can be made by
companies, but only if this is totally separated from promotional activity -
which usually means separated from representative activity.
Sampling
Sampling of medicines is permitted, but only if this
is done strictly in line with the detailed requirements of the Code. These
cover the number of samples, sample requests and delivery and control of
samples.
Meetings
The main requirement for company
organised or sponsored meetings is that they must be primarily educational
activities, rather than social events. Hospitality can be provided, but it must
comply with Code requirements in relation to cost, form and appropriateness to
the occasion and to the attendees. Again, the principle is that there should be
no suggestion that doctors are being wined and dined by
pharmaceutical companies and hence being unduly influenced in favour of their
products.
Summary
The principles in each of these
areas should be easy to appreciate. Less easy is to learn the many ways in
which the principles can impact on day to day representative activity. This
requires learning the detail of the Code, and also acquiring experience of the
Code in practice.
Sources of information
ABPI -
Association of the British Pharmaceutical Industry, the industry trade
association. www.abpi.org.uk
PMCPA - Prescription Medicines
Code of Practice Authority, the independent body within the ABPI which
administers the Code. See
www.abpi.org.uk/links/assoc/pmcpa.asp
Code of
Practice Review - published quarterly by the PMCPA and made widely and publicly
available. It contains full details of all complaints and rulings, naming
companies involved but not individuals. Copies of the latest issue are freely
available by contacting the PMCPA directly.
|
The
Author:
Joan Barnard, Medical Consultant, provides guidance and
training on the Code.
She is the author of The Code in Practice, for Head
Office staff, and The Code in the Field, a practical guide to the Code
for medical representatives. These books are available for a small cost by
contacting Joan directly.
Contact details:
Telephone 0208 341 2963 Email
barnardjo@aol.com |
Disclaimer
OnePharm Internet
excludes any warranty, express or implied, as to the quality, accuracy,
timeliness, completeness or fitness for a particular purpose of this briefing.
OnePharm Internet will not be liable for any claims, penalties, losses,
damages, costs, or expenses arising from the use of or inability to use this
briefing or from any unauthorised access to or alteration of the Briefing.
OnePharm Internet makes no warranty that the contents of this briefing are
compatible with all computer systems and browsers.
|